Safety and Efficacy of Sunitinib for Metastatic Renal Cell Carcinoma in Indian Population: A Tertiary Care Center Experience

Journal Title: New Indian Journal of Surgery - Year 2018, Vol 9, Issue 4

Abstract

Purpose: Our study aims to evaluate the efficacy & safety of targeted therapy (Sunitinib) for metastatic renal cell carcinoma (mRCC) in Indian population. Methods: The hospital records of total ninety four patients were reviewed retrospectively in this study who were offered sunitinib for mRCC between 2008 to 2015. Out of ninety four patients 16 pateints (neo-adjuvant cases) were excluded and 78 were included in this study. All patients received Tyrosine kinase inhibitor, sunitinib therapy (50 mg OD, 4/2 scheme). All 39 patients underwent radical nephrectomy prior to initiation of sunitinib therapy. Patients were followed up every cycle for their clinical symptoms following sunitinib therapy and at every 3 month with chest Xray, ultra-sonography and bone scan, CT scan (if required). The RECIST criterion was used to evaluate the overall tumor response. Results: The median survival was 28.5 months (range 9.253-47.7) and progression free survival (PFS) was 9.16 months (range 6.08-12.23). Clear cell histology was found in 60 (76.9%) patients, papillary variety in 12 (15.39%) patients, chromophobe type was seen in 2 patients and rest had mixed sarcamatoid papillary and rhabdoid clear cell variety. Forty eight patients (61.5%) had multiple metastases. Most frequent metastasis was seen in lungs in 28 patients (36%) and bone in 24 patients (31%). Metastasis was also seen in draining lymph nodes, adrenal, omentum, skin, liver, brain. Conclusion: In our study, use of sunitinib showed similar outcome to previously published articles. Our study supports the use of sunitinib in metastatic renal cell carcinoma.

Authors and Affiliations

Vashishtha Saurabh

Keywords

Related Articles

Clinical Study and Management of Scrotal Swellings in Adults

Scrotal swellings are one of the commonest surgical problems. Different scrotal swellings may be present, but many a times patients hesitate to come early and may come with late complications. Objectives of the Study: 1....

ICG Infrared Laparoscopic Cholangiography–An Approach to 0% Bile Duct Injury

Cholecystectomy is the treatment of choice for gall bladder stone since centuries. Bileduct injuries are associated with cholecystectomy since beginning. In last three decades gall bladder removal by laparoscopy has supe...

A Study on Risk Factors Affecting Surgical Site Infections at a Tertiary Care Hospital

Introduction: Surgical Site infections (SSI) still remain a significant problem following an operation and the third most frequently reported nosocomial infections. SSI contributes significantly to increase health care c...

Diagnosis and Management of Blunt Abdominal Trauma in Children: Experience from a Newly Established Facility

Background: Trauma is the leading cause of death in children in developed countries. In developing countries accidents are shown to be as numerous as in developed countries and it remains the major cause of blunt abdomin...

Abdominal Tuberculosis: Laparoscopy A Novel Tool for Diagnosis

Objective: To analyze the efficacy of diagnostic laparoscopy for diagnosing abdominal tuberculosis in susceptible cases. Methods: The records of 20 patients (15 males, 5 females, mean age 35, range 20-70 years) diagnosed...

Download PDF file
  • EP ID EP548063
  • DOI 10.21088/nijs.0976.4747.9418.5
  • Views 92
  • Downloads 0

How To Cite

Vashishtha Saurabh (2018). Safety and Efficacy of Sunitinib for Metastatic Renal Cell Carcinoma in Indian Population: A Tertiary Care Center Experience. New Indian Journal of Surgery, 9(4), 428-432. https://www.europub.co.uk/articles/-A-548063